• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无泵式14腔微生理系统的设计与演示

Design and demonstration of a pumpless 14 compartment microphysiological system.

作者信息

Miller Paula G, Shuler Michael L

机构信息

Department of Biomedical Engineering, Cornell University, 113 Weill Hall, Ithaca, 14853, New York.

出版信息

Biotechnol Bioeng. 2016 Oct;113(10):2213-27. doi: 10.1002/bit.25989. Epub 2016 Apr 29.

DOI:10.1002/bit.25989
PMID:27070809
Abstract

We describe a human "Body-on-a-chip" device (or microphysiological system) that could be used to emulate drug distribution, metabolism, and action in the body. It is based upon a physiologically based pharmacokinetic-pharmacodynamic (PBPK-PD) model, where multiple chambers representing different organs are connected with fluidic channels to mimic multi-organ interactions within the body. Here we describe a pumpless 14 chamber (13 organs) microfluidic cell culture device that provides a separation between barrier and nonbarrier types of cell cultures. Our barrier chamber layer (skin, GI tract, and lung) allows for direct access and/or exposures to chemical or biological reagents forcing these reagents to pass through a barrier of cells established on a microfabricated membrane before exposing the nonbarrier tissue chambers (fat, kidney, heart, adrenal glands, liver, spleen, pancreas, bone marrow, brain, muscle) or entering the microfluidic circulation within the device. Our nonbarrier tissue chambers were created as three-dimensional configurations by resuspending cells in hydrogel (PGMatrix). We used cell lines to represent five of these organs (barrier lines-A549 [lung] and Caco2 [GI]) (nonbarrier lines-HepG2 C3A [liver], Meg01 [bone marrow], and HK2 [kidney]). The dimensions of our straight duct-like channels to each organ chamber were designed to provide the appropriate flow of a culture medium. The organ volumes and organ flow rates that have been reported for an average human male were used to estimate the desired fluid retention times in each organ chamber. The flow through the channels was induced by gravity on a custom programmed rocker platform which enabled pumpless operation and minimized bubble entrapment. The purpose of this paper is to describe the design and operation of a 14 chamber multi-organ system representing 13 tissues/organs with both barrier and nonbarrier tissue chambers and to study the interactive responses among the various cell lines. We demonstrate that five different cell lines survived with high viability (above 85%) for 7 days. We compared the individual observed flow rates to the compartments to the desired or estimated flow rates. This work demonstrates the feasibility of constructing, operating and maintaining a simple, gravity-driven, multi-organ microphysiological system with the capability of measuring cellular functions such as CYP1A1 and CYP3A4 activities, albumin release, urea, maintenance of tight junctions, and presence of surfactant for a sustained period. Biotechnol. Bioeng. 2016;113: 2213-2227. © 2016 Wiley Periodicals, Inc.

摘要

我们描述了一种人体“芯片上的身体”装置(或微生理系统),可用于模拟药物在体内的分布、代谢和作用。它基于生理药代动力学 - 药效学(PBPK - PD)模型,其中代表不同器官的多个腔室通过流体通道相连,以模拟体内多器官间的相互作用。在此,我们描述了一种无泵的14腔室(13个器官)微流控细胞培养装置,该装置可实现屏障型和非屏障型细胞培养的分离。我们的屏障腔室层(皮肤、胃肠道和肺)允许直接接触和/或暴露于化学或生物试剂,迫使这些试剂在接触非屏障组织腔室(脂肪、肾脏、心脏、肾上腺、肝脏、脾脏、胰腺、骨髓、大脑、肌肉)或进入装置内的微流体循环之前,先穿过在微制造膜上建立的细胞屏障。我们的非屏障组织腔室通过将细胞重悬于水凝胶(PGMatrix)中形成三维结构。我们使用细胞系来代表其中五个器官(屏障细胞系 - A549[肺]和Caco2[胃肠道])(非屏障细胞系 - HepG2 C3A[肝脏]、Meg01[骨髓]和HK2[肾脏])。我们为每个器官腔室设计的直管状通道尺寸,旨在提供合适的培养基流速。利用已报道的平均成年男性的器官体积和器官流速,来估计每个器官腔室内所需的液体保留时间。通道内的流动由定制编程的摇床平台上的重力诱导,该平台实现了无泵操作并将气泡截留降至最低。本文的目的是描述一个14腔室多器官系统的设计与操作,该系统代表13个组织/器官,包含屏障和非屏障组织腔室,并研究各种细胞系之间的相互作用反应。我们证明了五种不同的细胞系在7天内以高存活率(高于85%)存活。我们将各个腔室观察到的流速与期望或估计的流速进行了比较。这项工作证明了构建、操作和维持一个简单的、重力驱动的多器官微生理系统的可行性,该系统能够在一段持续时间内测量细胞功能,如CYP1A1和CYP3A4活性、白蛋白释放、尿素、紧密连接的维持以及表面活性剂的存在。《生物技术与生物工程》2016年;113卷:2213 - 2227页。©2016威利期刊公司

相似文献

1
Design and demonstration of a pumpless 14 compartment microphysiological system.无泵式14腔微生理系统的设计与演示
Biotechnol Bioeng. 2016 Oct;113(10):2213-27. doi: 10.1002/bit.25989. Epub 2016 Apr 29.
2
Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue.用于胃肠道上皮细胞和 3D 原代肝组织共培养的模块化、无泵体芯片平台。
Lab Chip. 2016 Jul 5;16(14):2719-29. doi: 10.1039/c6lc00461j.
3
UniChip enables long-term recirculating unidirectional perfusion with gravity-driven flow for microphysiological systems.UniChip 可实现基于重力驱动的长周期循环单向灌流,用于微生理系统。
Lab Chip. 2018 Aug 21;18(17):2563-2574. doi: 10.1039/c8lc00394g.
4
A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells.一种使用人肠细胞原代培养物和肝实质细胞 3D 培养物的无泵体芯片模型。
Lab Chip. 2018 Jul 10;18(14):2036-2046. doi: 10.1039/c8lc00111a.
5
A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip.一种用于芯片上药代动力学-药效学(PK-PD)模型的微流控装置。
Lab Chip. 2010 Feb 21;10(4):446-55. doi: 10.1039/b917763a. Epub 2010 Jan 5.
6
Multiorgan microfluidic platform with breathable lung chamber for inhalation or intravenous drug screening and development.多器官微流控平台,具有可呼吸的肺室,用于吸入或静脉内药物筛选和开发。
Biotechnol Bioeng. 2020 Feb;117(2):486-497. doi: 10.1002/bit.27188. Epub 2019 Nov 25.
7
A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model.一种与药代动力学-药效学(PK-PD)模型相结合的无泵多器官芯片(MOC)。
Biotechnol Bioeng. 2017 Feb;114(2):432-443. doi: 10.1002/bit.26087. Epub 2016 Sep 14.
8
Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.基于生理学的药代动力学/药效学建模的芯片上人体设计策略与原则。
Integr Biol (Camb). 2015 Apr;7(4):383-91. doi: 10.1039/c4ib00292j.
9
Pumpless, unidirectional microphysiological system for testing metabolism-dependent chemotherapeutic toxicity.无泵、单向微生理系统,用于测试代谢依赖性化疗毒性。
Biotechnol Prog. 2021 Mar;37(2):e3105. doi: 10.1002/btpr.3105. Epub 2020 Dec 16.
10
Self-contained, low-cost Body-on-a-Chip systems for drug development.用于药物研发的独立式低成本芯片人体系统。
Exp Biol Med (Maywood). 2017 Nov;242(17):1701-1713. doi: 10.1177/1535370217694101. Epub 2017 Feb 17.

引用本文的文献

1
Multi-Organ Microphysiological Systems Targeting Specific Organs for Recapitulating Disease Phenotypes via Organ Crosstalk.通过器官间相互作用针对特定器官模拟疾病表型的多器官微生理系统。
Small Sci. 2024 Sep 19;4(11):2400314. doi: 10.1002/smsc.202400314. eCollection 2024 Nov.
2
Fabrication of a novel 3D-printed perfusion bioreactor for complex cell culture models.用于复杂细胞培养模型的新型3D打印灌注生物反应器的制造。
Sci Rep. 2025 Mar 24;15(1):10134. doi: 10.1038/s41598-025-94093-z.
3
Revolutionizing Biomedical Research: Unveiling the Power of Microphysiological Systems with Advanced Assays, Integrated Sensor Technologies, and Real-Time Monitoring.
变革生物医学研究:通过先进检测方法、集成传感器技术和实时监测揭示微生理系统的力量。
ACS Omega. 2025 Mar 10;10(10):9869-9889. doi: 10.1021/acsomega.4c11227. eCollection 2025 Mar 18.
4
Microphysiological system to address the opioid crisis: A novel multi-organ model of acute opioid overdose and recovery.应对阿片类药物危机的微生理系统:一种新型的急性阿片类药物过量及恢复的多器官模型。
Curr Res Toxicol. 2024 Dec 18;8:100209. doi: 10.1016/j.crtox.2024.100209. eCollection 2025.
5
Development of a Microphysiological System to Model Human Cancer Metastasis From the Colon to the Liver.开发一种微生理系统以模拟人类结肠癌转移至肝脏的过程。
Biotechnol Bioeng. 2025 Mar;122(3):481-494. doi: 10.1002/bit.28890. Epub 2024 Nov 25.
6
A gravity-driven tissue chip to study the efficacy and toxicity of cancer therapeutics.一种基于重力的组织芯片,用于研究癌症治疗药物的疗效和毒性。
Lab Chip. 2024 Nov 19;24(23):5251-5263. doi: 10.1039/d4lc00404c.
7
Modelling the innate immune system in microphysiological systems.在微生理系统中模拟先天免疫系统。
Lab Chip. 2024 Jul 23;24(15):3604-3625. doi: 10.1039/d3lc00812f.
8
Construction, Features and Regulatory Aspects of Organ-chip for Drug Delivery Applications: Advances and Prospective.用于药物输送应用的器官芯片的构建、特点和调控方面:进展与展望。
Curr Pharm Des. 2024;30(25):1952-1965. doi: 10.2174/0113816128305296240523112043.
9
Advancing Organoid Engineering for Tissue Regeneration and Biofunctional Reconstruction.推进用于组织再生和生物功能重建的类器官工程
Biomater Res. 2024 Apr 15;28:0016. doi: 10.34133/bmr.0016. eCollection 2024.
10
Revolutionizing nephrology research: expanding horizons with kidney-on-a-chip and beyond.变革肾脏病学研究:借助芯片肾脏及其他技术拓展视野
Front Bioeng Biotechnol. 2024 Mar 28;12:1373386. doi: 10.3389/fbioe.2024.1373386. eCollection 2024.